ArticleCancer research2009

Dual inhibition of class IA phosphatidylinositol 3-kinase and mammalian target of rapamycin as a new therapeutic option for T-cell acute lymphoblastic leukemia.

Francesca Chiarini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.